BlackRock Inc. (NYSE: EMN) holds 13.8% of Eastman Chemical in 13G/A filing

Rhea-AI Filing Summary

BlackRock, Inc. filed Amendment No. 16 to a Schedule 13G/A reporting beneficial ownership in Eastman Chemical Co. The filing states BlackRock's Reporting Business Units beneficially own 15,745,661 shares of Common Stock, representing 13.8% of the class. The filing lists 15,437,852 shares as sole voting power and identifies iShares Core S&P Small-Cap ETF as a holder with more than 5% of the class. The filing was signed by Spencer Fleming on 04/24/2026.

Insights

Institutional Ownership Analyst

BlackRock's amendment confirms a sizable passive ownership stake in Eastman Chemical.

The filing reports 15,745,661 shares beneficially owned by BlackRock Reporting Business Units, equal to 13.8% of the class as of 03/31/2026. The filing distinguishes voting and dispositive powers and names a >5% interest holder.

Monitor subsequent amendments or issuer disclosures for any change in position or voting alignment; timing and cash‑flow treatment are not stated in the excerpt.

Regulatory Compliance Specialist

The Schedule 13G/A aligns with passive reporting requirements and includes required exhibits.

The submission references Exhibit 24 (Power of Attorney) and Exhibit 99 (Item 7) and follows SEC Release No. 34-39538 aggregation rules for Reporting Business Units. It identifies the Reporting Business Units as the source of the disclosed holdings.

Ensure future filings specify any change from passive to active intent or list additional subsidiaries if classification shifts.

Key Figures

Beneficially owned shares: 15,745,661 shares Percent of class: 13.8% Sole voting power: 15,437,852 shares +3 more

6 metrics

Beneficially owned shares 15,745,661 shares Amount beneficially owned reported on the Schedule 13G/A

Percent of class 13.8% Percent of common stock represented by reported holdings

Sole voting power 15,437,852 shares Shares for which BlackRock has sole power to vote

Filing signature date 04/24/2026 Date the amendment was signed by Spencer Fleming

Reporting as of 03/31/2026 Date appearing on the cover header of the filing

CUSIP 277432100 CUSIP for Eastman Chemical common stock shown on the filing

Key Terms

Beneficially owned, Sole dispositive power, Schedule 13G/A, Reporting Business Units

4 terms

Beneficially owned regulatory

"Amount beneficially owned: 15745661"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 15745661"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Schedule 13G/A regulatory

"In accordance with SEC Release No. 34-39538 (January 12, 1998), this reflects the securities beneficially owned"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Reporting Business Units other

"beneficially owned by certain business units (collectively, the "Reporting Business Units")"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 04:11 PM Learn about SEC filing dates

FAQ

What stake does BlackRock report in Eastman Chemical (EMN)?

BlackRock reports beneficial ownership of 15,745,661 shares, equal to 13.8% of the class. The Schedule 13G/A shows 15,437,852 shares where BlackRock has sole voting power and lists related exhibits and signature details.

Does BlackRock control voting for the shares it reports in EMN?

The filing shows BlackRock has sole voting power over 15,437,852 shares and sole dispositive power over 15,745,661 shares. The filing attributes holdings to Reporting Business Units under SEC aggregation guidance.

Is any other entity named as owning more than 5% of EMN in this filing?

Yes—iShares Core S&P Small-Cap ETF is identified as having an interest exceeding 5% of Eastman Chemical's common stock. The filing notes this interest under Item 6 as required by Schedule 13G/A rules.

What date applies to the ownership figures in the Schedule 13G/A?

The ownership figures are presented with an apparent anchor of 03/31/2026 in the cover header; the amendment was signed on 04/24/2026 by Spencer Fleming. The filing text lists the reported share counts and percentages.

What exhibits accompany this Schedule 13G/A amendment?

The amendment references Exhibit 24 (Power of Attorney) and Exhibit 99 (Item 7 identification/classification of relevant subsidiary). These exhibits are standard for parent/subsidiary reporting arrangements.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 16)

EASTMAN CHEMICAL CO

(Name of Issuer)

Common Stock

(Title of Class of Securities)

277432100

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 277432100

1

Names of Reporting Persons

BlackRock, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 15,437,852.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 15,745,661.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

15,745,661.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.8 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: EASTMAN CHEMICAL CO
(b)	Address of issuer's principal executive offices: 200 South Wilcox Drive KINGSPORT TN 37660
Item 2.
(a)	Name of person filing: BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)	Address or principal business office or, if none, residence: BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)	Citizenship: See Item 4 of Cover Page
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 277432100
Item 4.	Ownership
(a)	Amount beneficially owned: 15745661
(b)	Percent of class: 13.8 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 15437852
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 15745661
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The interest of 1 such person, iShares Core S&P Small-Cap ETF, in the common stock of EASTMAN CHEMICAL CO is more than five percent of the total outstanding common stock.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BlackRock, Inc.

Signature:	Spencer Fleming
Name/Title:	Managing Director
Date:	04/24/2026

Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7